Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Year-end report April 2018 – March 2019

CEO’s comments The last quarter of the financial year 2019/20 was a good quarter for EQL Pharma, with sales of SEK 14.6 million (7.0), an increase of 107%. For the full financial year, sales were SEK 50.0 million (28.6), an increase of 75%. Profitability also developed well, albeit from low levels, with an EBITDA result of SEK 3.4 million (0.9). The gross margin was 56% (54%), an indication that our product portfolio continues to feel a relatively low competitive pressure. Several new product launches during the fiscal year have contributed to the strong growth, such as potassium chloride,

Invitation to telephone conference / audiocast – Q1 2019

Boozt AB’s (publ) Q1 2019 report will be published on Wednesday the 15th of May at 08.00 CET.At 09.30 CET on the same day, Boozt’s CEO, Hermann Haraldsson, and CFO, Allan Junge-Jensen, will present the Interim Report at a telephone conference / audiocast. The presentation will be held in English and will be followed by a Q&A session. Questions can be asked via the telephone conference or in written form via the audiocast. No registration is needed. The presentation material will be available at Boozt’s website . How to participate in the telephone

Itiviti gears up to accelerate sell-side OMS adoption, providing upgrade path for Bloomberg SSEOMS clients

London, UK, May 8th, 2019 – Itiviti, a leading technology and service provider to financial institutions worldwide, today announced that its multi-asset Order Management System (OMS) has been selected by several customers who were currently using Sell-Side Execution and Order Management Solutions (SSEOMS) from Bloomberg L.P. Following Bloomberg’s recent announcement that the firm will discontinue its SSEOMS product, clients need to consider other options.In recent years Itiviti has successfully migrated a number of Bloomberg SSEOMS clients to its sell-side trading platform, which includes

Ficolo Invests Over 50 Million Euros in Building a Cloud Delivery Center, Making it the Largest Domestic Player in the Market

The data center and cloud delivery company Ficolo buys a data center in Vantaa and will make a major investment to expand it into a modern Cloud Delivery Center. The total investment amounts to over 50 million euros, most of which will be used during the first 12 months. The investment will take Ficolo’s business to a new level, place the Helsinki metropolitan area at the forefront of the data center industry in Europe, and improve Finland’s competitiveness as a provider of next-generation IoT and Industrial Internet solutions.Ficolo and Fujitsu have signed a cooperation agreement as part

GoldBlue decides on a rights issue of approximately SEK 16.9 million and publishes new financial information

GoldBlue AB (publ) Press release 8 May 2019   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL, BE SUBJECT TO LEGAL RESTRICTIONS OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES.   GoldBlue decides on a rights issue of approximately SEK 16.9 million and publishes new financial information The Board of Directors of GoldBlue AB (

NOTICE OF EXTRAORDINARY GENERAL MEETING IN GOLDBLUE AB (PUBL)

The shareholders of GoldBlue AB (publ), org. no 559078-0465, are hereby convened to an extraordinary general meeting to be held on Friday 7th of June 2019 at 01:00 pm at Advokatfirma DLA Piper Sweden's office, Kungsgatan 9 in Stockholm, Sweden. Right to attend To have the right to attend the extraordinary general meeting, the shareholder needs to be registered in the share register maintained by Euroclear Sweden AB by Friday 31st of May 2019 and shall notify the company of its participation no later than the 3rd of June 2019. Shareholders with nominee-registered shares must, well

Demeter Finance closes offer in DDM Holding AG with almost 80 percent

THE OFFER IS NOT BEING MADE, AND THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO, NOR WILL ANY TENDER OF SHARES BE ACCEPTED FROM OR ON BEHALF OF HOLDERS IN, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA OR THE UNITED STATES OF AMERICA, OR ANY OTHER JURISDICTION IN WHICH THE MAKING OF THE OFFER, THE DISTRIBUTION OF THIS PRESS RELEASE OR THE ACCEPTANCE OF ANY TENDER OF SHARES WOULD CONTRAVENE APPLICABLE LAWS OR REGULATIONS OR REQUIRE FURTHER OFFER DOCUMENTS, FILINGS OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED UNDER SWEDISH LAW.Demeter Finance

The NextCell Pharma AB board of directors proposes an Rights Issue of MSEK 24.9 and calls for an extraordinary general meeting

The Board of NextCell Pharma AB (publ) ("NextCell" or "the Company") has decided to propose an extraordinary general meeting on May 24, 2019 to decide on a rights issue of shares ("Rights Issue") totaling SEK 24.9 million. The rights issue is secured through subscription commitments and letter of intent of approximately 21 per cent and guarantee commitments of approximately 59 per cent, which corresponds to approximately 80 per cent of the total issue volume.The reason for the rights issue is to obtain working capital to expand the clinical trial program with the company's first drug

Interim Financial Report January – March 2019

The first quarter of 2019 turned out slightly better than expected and we can see that the activities we have undertaken to create a better underlying profitability are starting to pay off. Compared to last year, LEAX Group revenue grew with 7% and EBITDA increased with 21% (excluding effects from IFRS 16). The outlook for the year looks stable and we are following the demands from our customers closely to be able to react if we see changes. Highlights of the first quarter of 2019 -          Net Sales amounted to SEK 505,6 million (473,2) -          Adjusted operating profit

New Composition of Basware Corporation’s Executive Team

Basware Corporation, stock exchange release, May 8, 2019 at 9:30 am EESTBasware is creating a leaner, more focused executive team. The executive team will be comprised of the following roles: · Chief Executive Officer, Klaus Andersen (Acting) · Chief Financial Officer, Tuija Mäntyniemi (Acting) · Chief Technology Officer, Klaus Andersen · SVP Global Sales, Paul Taylor · Chief Marketing Officer, Lars Madsen · SVP Customer Services, Jussi Vasama · SVP Human Resources, Jane Broberg Mikko Pilkama and Eric Wilson will leave the executive team and the company during

AVTECH Sweden AB (publ) INTERIM REPORT January - March 2019

· AVTECH Group's turnover for the first quarter of 2019 amounted to MSEK 4.1 (2.8).  · Operating profit before depreciation for the first quarter of 2019 was MSEK +0.9 (+0.3).   · The net result for the first quarter of 2019 amounted to MSEK +0.1 (-0.9) or SEK 0.04 (0.04) per share.  · Cash flow from operating activities for the first quarter of 2019 amounted to MSEK -1.0 (-0.3). The Group's cash and cash equivalents at the end of the period amounted to MSEK 14.1 (15.7 at the end of the year). Increased market efforts of approximately SEK 0.8 million have affected liquidity during

2cureX publishes interim report for the first quarter of 2019

2cureX AB (“2cureX”) hereby publishes the interim report for the first quarter of 2019. The interim report is available as an attached document as well as on the company’s website (www.2curex.com). Below follows a short summary of the report.CEO Ole Thastrup comments “We have started 2019 with great momentum and during the first three months we have been able to achieve several value-driving activities. We have among other things strengthened the organization through the recruitment of a CFO, presented successful interim results from the ongoing validation study in colorectal cancer and

Mats Johnson appointed new CEO of Speed Group

Mats Johnson has been appointed as the new CEO of Speed Group, a leading supplier of logistics and staffing services. Mats will join the company from his role as Logistics Director at Tamro and will assume his new position in December 2019 at the latest. Until then, Jan Krepp will continue to serve as acting CEO.Mats has spent his entire career in the logistics sector, having served as Managing Director of Schenker Logistics AB before assuming his current role as Logistics Director at Tamro. During his time at Tamro, Mats has led the company’s efforts to adapt its operations to Sweden’s re-

C-RAD AB – Interim report January-March 2019

C-RAD AB – Interim report January-March 2019 REVENUE INCREASE OF 40 PERCENT JANUARY - MARCH 2019  · Revenues: 47.3 (33.8) MSEK · Order intake: 47.8 (50.6) MSEK · EBITDA: 3.6 (-3.6) MSEK · Operating profit: 1.2 (-4.7) MSEK   · Net results after tax: 0.8 (-4.9) MSEK · Result per share: 0.02 (-0.16) SEK. · Strategic development and sales cooperation with Xecan. · Order from Community Health Network (US), value 11 MSEK. · Therése Björklund appointed interim CFO following Cecilia DanckwardtLillieström   Presentation of the interim reportCEO Tim

Follicum receives patent grant in Europe - broadened protection for lead candidate FOL-005

Follicum has received an official grant of patent from the European Patent Office, EPO regarding the company's broadened patent application for stimulation of hair growth. The official grant follows the "Intention to Grant" which was communicated on November 21, 2018.With EPO's grant of patent no. EP 3087999 B1, there is now broad protection for Follicum's peptides in Europe until 2032. The patent that protects the company's peptides generally as a product, and for the stimulation of hair growth specifically, is a broadening of the previously granted, first patent on FOL-005. The patent

Interim Report January – March 2019

First quarter in brief · Net sales rose by about 91 percent to SEK 11,931 (6,246) thousand. · Operating profit/loss before depreciation and amortization (EBITDA) totaled SEK 2,695 (loss: 16) thousand. · Operating profit/loss improved by SEK 3,310 thousand to SEK 1,942 (loss: 1,368) thousand. · Comprehensive income for the quarter improved by SEK 2,987 thousand and totaled 1,591 (loss: 1,396) thousand. · Comprehensive income per share, basic and diluted, improved by SEK 0.05 to SEK 0.03 (-0.02). · Cash flow from operating activities was SEK 2,709 (loss: 2,024)

Finnair Traffic Performance in April 2019

Finnair Plc                 Investor News        8 May 2019 at 9:10 am The number of passengers carried in April increased by 14.8% year-on-year while capacity growth remains strong In April. Finnair carried 1,227,400 passengers. 14.8% more than in the corresponding period of 2018. The overall capacity measured in Available Seat Kilometres (ASK) increased in April by 19.6%. Finnair's traffic measured in Revenue Passenger Kilometres (RPKs) increased by 17.8%. The Passenger Load Factor (PLF) decreased year-on-year by 1.2% points to 81.4%.   Finnair’s long-haul capacity increased year-

Etrion Releases First Quarter 2019 Results

May 8, 2019, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three months ended March 31, 2019.  Etrion Corporation delivered strong project-level results in the first quarter of 2019 from its Japanese assets. Higher installed capacity and electricity production resulted in a significant increase in revenue and consolidated EBITDA compared to the same period in 2018. Q1-

Changes in Outotec's own shares

OUTOTEC OYJ   STOCK EXCHANGE RELEASE   MAY 8, 2019 at 9.05 AM Changes in Outotec's own shares Outotec's Board of Directors has decided to issue Outotec shares held by the company for the payment of free shares of Outotec's Employee Share Savings Plan from the 2016 savings period. Outotec's Employee Share Savings Plan is offered for all employees globally in countries where there are no local legal, taxation or administrative restraints. Employees participating in the Plan save a proportion of their salary for purchasing Outotec shares. For the 2016 savings period, Outotec

Gasmet Technologies acquires MonitoringSystems GmbH for expansion in solutions for industrial emissions monitoring

Gasmet Technologies Oy, a Finnish gas analyzer and emissions monitoring systemmanufacturer, has announced its acquisition of MonitoringSystems GmbH, based in Austria. Acquisition further strengthens Gasmet’s global position as one of the leading gas monitoring equipment providers.Gasmet, founded in 1990, is the leading FTIR gas analyzer and emissions monitoring system provider with 30 years of FTIR experience.  Gasmet offers complete solutions for monitoring industrial emissions and portable instruments to study climate change and ensure people’s safety. The company has supplied more

Vestas - Interim financial report, first quarter 2019

Vestas Wind Systems A/S, Aarhus, 8 May 2019Company announcement No. 09/2019 Summary: Revenue on par with last year’s first quarter while earnings and free cash flow decreased. Solid order intake and combined order backlog at all-time high level. Guidance for 2019 maintained.  In the first quarter of 2019, Vestas generated revenue of EUR 1,730m – an increase of 2 percent compared to the year-earlier period. EBIT before special items decreased by EUR 83m to EUR 43m. The EBIT margin was 2.5 percent compared to 7.4 percent in the first quarter of 2018 and free cash flow* amounted to EUR

Nordstjernan acquires shares in Attendo from Pertti Karjalainen

Nordstjernan has acquired 2,221,930 shares for a total consideration of approximately SEK 111 million from Pertti Karjalainen, CEO Attendo Finland, who wants to reduce his debt position. Following the transaction, Nordstjernan’s ownership in Attendo amounts to 17.3 percent of the capital and voting rights, and Karjalainen’s ownership in Attendo amounts to 12.8 percent of the capital and voting rights. The consideration per share has been calculated based on the volume-weighted average share price during the last 15 trading days. Tomas BillingCEONordstjernan AB Questions will be

BioGaia AB Interim management statement 1 January – 31 March 2019

Comments from the CEO:Sales during the first quarter increased by 9% (excluding foreign exchange effects, 2%) compared to the corresponding period last year. Sales of products, excluding royalty revenues, increased by 19% (excluding foreign exchange effects, 11%). Our largest product, BioGaia Protectis baby drops, increased in all markets and our Adult Health portfolio, with above all BioGaia Protectis tablets and BioGaia Prodentis lozenges, grew by 54% which is the result of focus on this target group. Sales in the Americas decreased by 9% which is a consequence of quarterly variations.

Trastuzumab deruxtecan demonstrated clinically

8 May 2019 07:00 BST Trastuzumab deruxtecan demonstrated clinically-meaningful response inpatients with refractory HER2-positive metastatic breast cancer, a population with high unmet need Pivotal Phase II DESTINY-Breast01 trial met primary endpoint,supporting global regulatory submission plan to start in H2 2019 AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) today announced positive top-line results for the pivotal Phase II DESTINY-Breast01 trial of trastuzumab deruxtecan (DS-8201). The HER2-targeting antibody drug conjugate (ADC) and potential new medicine

There are no items matching the current filter
There are no more items matching the current filter
Back to top